Literature DB >> 12161487

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study.

A Elisabeth Hak1, Jacqueline C M Witteman, Frank H de Jong, Mirjam I Geerlings, Albert Hofman, Huibert A P Pols.   

Abstract

In both men and women, circulating androgen levels decline with advancing age. Until now, results of several small studies on the relationship between endogenous androgen levels and atherosclerosis have been inconsistent. In the population-based Rotterdam Study, we investigated the association of levels of dehydroepiandrosterone sulfate (DHEAS) and total and bioavailable testosterone with aortic atherosclerosis among 1,032 nonsmoking men and women aged 55 yr and over. Aortic atherosclerosis was assessed by radiographic detection of calcified deposits in the abdominal aorta, which have been shown to reflect intimal atherosclerosis. Relative to men with levels of total and bioavailable testosterone in the lowest tertile, men with levels of these hormones in the highest tertile had age-adjusted relative risks of 0.4 [95% confidence interval (CI), 0.2-0.9] and 0.2 (CI, 0.1-0.7), respectively, for the presence of severe aortic atherosclerosis. The corresponding relative risks for women were 3.7 (CI, 1.2-11.6) and 2.3 (CI, 0.7-7.8). Additional adjustment for cardiovascular disease risk factors did not materially affect the results in men, whereas in women the associations diluted. Men with levels of total and bioavailable testosterone in subsequent tertiles were also protected against progression of aortic atherosclerosis measured after 6.5 yr (SD +/- 0.5 yr) of follow-up (P for trend = 0.02). No clear association between levels of DHEAS and presence of severe aortic atherosclerosis was found, either in men or in women. In men, a protective effect of higher levels of DHEAS against progression of aortic atherosclerosis was suggested, but the corresponding test for trend did not reach statistical significance. In conclusion, we found an independent inverse association between levels of testosterone and aortic atherosclerosis in men. In women, positive associations between levels of testosterone and aortic atherosclerosis were largely due to adverse cardiovascular disease risk factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161487     DOI: 10.1210/jcem.87.8.8762

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  104 in total

1.  Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels.

Authors:  Katerina Saltiki; George Papageorgiou; Paraskevi Voidonikola; Emily Mantzou; Konstantinos Xiromeritis; Christos Papamichael; Maria Alevizaki; Kimon Stamatelopoulos
Journal:  Endocrine       Date:  2010-01-16       Impact factor: 3.633

Review 2.  Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.

Authors:  Wayne J G Hellstrom; Darius Paduch; Craig F Donatucci
Journal:  Int Urol Nephrol       Date:  2010-12-09       Impact factor: 2.370

3.  The use of hormonal therapy in "andropause": the pro side.

Authors:  Alvaro Morales
Journal:  Can Urol Assoc J       Date:  2008-02       Impact factor: 1.862

4.  Dr. Morales' rebuttal.

Authors:  Alvaro Morales
Journal:  Can Urol Assoc J       Date:  2008-02       Impact factor: 1.862

5.  Low serum testosterone increases mortality risk among male dialysis patients.

Authors:  Juan Jesús Carrero; Abdul Rashid Qureshi; Paolo Parini; Stefan Arver; Bengt Lindholm; Peter Bárány; Olof Heimbürger; Peter Stenvinkel
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

6.  Sex steroid hormone concentrations and risk of death in US men.

Authors:  Andy Menke; Eliseo Guallar; Sabine Rohrmann; William G Nelson; Nader Rifai; Norma Kanarek; Manning Feinleib; Erin D Michos; Adrian Dobs; Elizabeth A Platz
Journal:  Am J Epidemiol       Date:  2010-01-18       Impact factor: 4.897

7.  Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.

Authors:  C J Malkin; P J Pugh; P D Morris; K E Kerry; R D Jones; T H Jones; K S Channer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

8.  Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial.

Authors:  Vivian N Hawkins; Karen Foster-Schubert; Jessica Chubak; Bess Sorensen; Cornelia M Ulrich; Frank Z Stancyzk; Stephen Plymate; Janet Stanford; Emily White; John D Potter; Anne McTiernan
Journal:  Med Sci Sports Exerc       Date:  2008-02       Impact factor: 5.411

Review 9.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Androgen therapy with dehydroepiandrosterone.

Authors:  Jacques Buvat
Journal:  World J Urol       Date:  2003-10-10       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.